Find Peptide Clinics
Clinic partner placement is available in select cities.View listing options

Peptide and GLP-1 Clinic Red Flags: What to Check Before You Pay

Find Peptide Clinics Editorial Desk

Some advertising for peptide and GLP-1 programs leans on four selling points: a membership fee, a promise that the drug comes from a partner pharmacy, a discount for paying several months at once, and a monthly price that moves with the dose. Each can be an ordinary business arrangement, and each can hide a term you would not have accepted if it had been written plainly. This guide covers the second case, names no company, and links the primary source behind each answer.

The short checklist

  • Ask which pharmacy will fill the prescription, by name.
  • Ask whether that pharmacy compounds under section 503A or registers with FDA as a 503B outsourcing facility, then look it up yourself.
  • Ask for the all-in monthly cost: drug, consult, membership, labs, shipping, and supplies.
  • Ask what the membership fee covers, and whether the program can be bought without it.
  • Ask whether the price changes when the dose changes, and what the higher amount pays for.
  • Ask for cancellation and refund terms in writing before any card number is entered.
  • Ask how many months a single payment covers.
  • Ask for the prescriber’s full name, credential, and state, then check that state’s board.
  • Ask whether the product is an FDA-approved brand drug or a compounded preparation.
  • Do not buy a peptide labeled “for research use only” or “not for human consumption”; FDA says consumers should not purchase these products.

Why these four ad claims are worth a question

Each is a contract term, and the point of asking is to get it in writing.

A membership fee: ask what it covers

The FTC’s consumer guidance on subscriptions tells shoppers to find the terms and conditions for an offer, because they should state what you are agreeing to, the length of the commitment, and how and when to cancel (FTC, Getting In and Out of Free Trials, Auto-Renewals, and Negative Option Subscriptions). Federal law also requires internet sellers that use a negative option feature to disclose all material terms before taking billing information, obtain express informed consent, and give a simple mechanism to stop recurring charges (Restore Online Shoppers’ Confidence Act, 15 U.S.C. 8401 to 8405). A membership fee is one of those terms. Ask what it buys and what the monthly total is with it included.

The provider cannot name the pharmacy: ask who fills the prescription

If the seller cannot name the pharmacy, you cannot check it, and the pharmacy prepares or dispenses what arrives. FDA advises consumers to check a pharmacy’s license through the state board of pharmacy, and states that if the pharmacy is not listed in that database, you should not use it (FDA, Locate a State-Licensed Online Pharmacy). FDA’s published list of telehealth warning signs includes a dispensing label carrying a pharmacy name the buyer thinks might be fraudulent, and a label with spelling errors or an incorrect pharmacy address (FDA, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss). A vague answer about a partner network is not a name you can look up.

Several months paid up front: ask for the cancellation terms

The same statute requires a simple mechanism to stop recurring charges (Restore Online Shoppers’ Confidence Act). Before a multi-month payment, ask what comes back if you stop after month one, in what form, and how long a refund takes. Ask whether the refund covers the drug, the membership, or neither, and how to cancel in writing rather than by phone.

A price that rises with the dose: ask what changes

Dose-based pricing can track the amount of drug in the vial. It can also track a schedule that was never disclosed. Ask at which dose the price changes, by how much, and what the higher amount covers. Ask for the label concentration and how many days one vial should last, then compare with the monthly charge.

Is compounded semaglutide FDA approved?

No. Compounded drugs are not FDA-approved, and, in FDA’s words, “FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed” (FDA, Compounding and the FDA: Questions and Answers). FDA repeats the point on its page about the risks of compounded drugs (FDA, Understanding the Risks of Compounded Drugs). It also states that compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug (FDA, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss).

Three specifics follow.

  • Salt forms. FDA states that semaglutide sodium and semaglutide acetate are different active ingredients than the ones used in the approved drugs, that it lacks information on whether these salts have the same chemical and pharmacological properties, and that it is not aware of any lawful basis for their use in compounding (FDA).
  • Ingredients outside compounding. FDA states that retatrutide and cagrilintide cannot be used in compounding under federal law (FDA).
  • Claims of sameness. FDA’s warning list for telehealth consumers includes claiming that a compounded drug is the same as an FDA-approved drug, and offering medicine at deep discounts or prices that seem too good to be true (FDA).

What is a 503A pharmacy, and what is a 503B outsourcing facility?

Section 503A of the federal Food, Drug, and Cosmetic Act describes when a state pharmacy can compound a drug, one condition being that it is compounded for an identified patient under a valid prescription. Section 503B created a separate, voluntary category of compounders called outsourcing facilities, which must follow current good manufacturing practice requirements, are inspected by FDA on a risk-based schedule, and must report adverse events (FDA, Human Drug Compounding Laws). Oversight splits on the same line: state boards of pharmacy hold primary responsibility for day-to-day oversight of pharmacies that are not registered as outsourcing facilities, while FDA primarily oversees facilities registered under section 503B (FDA).

How do I check a clinic’s pharmacy?

Two lookups cover most of it. If the pharmacy is described as a 503B outsourcing facility, search FDA’s registration table, which lists every facility registered under section 503B with the last inspection, whether a Form 483 was issued, and whether a recall was conducted (FDA, Registered Outsourcing Facilities). If the name is missing, ask why.

If the pharmacy is a state pharmacy, use the license database for its state board. FDA publishes links to every state board lookup, with three checks to run once a pharmacy appears: that it requires a doctor’s prescription, that it gives a physical address and a telephone number in the United States, and that it has a pharmacist available to answer questions (FDA, Locate a State-Licensed Online Pharmacy). FDA’s BeSafeRx campaign collects the consumer version of the same advice, including how to report a website that appears to be selling medicine unlawfully (FDA, BeSafeRx). Registration under section 503B is a registration, not an approval of any product (FDA).

How do I check the prescriber?

Ask for the full name, the credential, and the state where the prescription will be written, then check the board that issues it. For physicians and physician assistants, DocInfo, run by the Federation of State Medical Boards, verifies a doctor’s license, background, and any actions taken by state medical boards (DocInfo). FDA’s warning list also flags a company with no licensed doctor available to answer questions after the medicine arrives (FDA). Ask who answers clinical questions in week two.

What should happen before a prescription is written?

FDA lists, as a telehealth red flag, a company that does not require a screening and prescription by a licensed doctor before providing medicine (FDA). Ask what the intake covers: health history, current medications, allergies, prior GLP-1 use, and whether labs or records are required before a prescription is issued.

What is the all-in monthly cost?

Ask for a single number covering drug, consult, membership, labs, shipping, and supplies, and ask which of those can be removed. FTC guidance on auto-renewals notes that a renewal can cost more than the previous payment when an introductory rate ends (FTC). A quoted price that leaves out a membership or a shipping charge is not the monthly cost.

What about peptides labeled for research use only?

FDA states that it has warned companies that illegally sold unapproved drugs containing semaglutide, tirzepatide, retatrutide, survodutide or mazdutide falsely labeled “for research purposes” or “not for human consumption”, that these products were sold directly to consumers for human use with dosing instructions, and that consumers should not purchase them because they are of unknown quality and may be harmful to health (FDA).

To look up a specific clinic, use the clinic checker, and for local options see the clinic directory or the peptide clinic hub. Related guides cover questions to ask before paying a peptide clinic, what to check at a GLP-1 clinic, how to spot a bad semaglutide clinic, the eight checks for a 503A pharmacy, FDA’s warning letter to a compounding pharmacy over GLP-1 claims, which popular peptides carry an FDA approval, and where BPC-157 stands legally.

Frequently asked questions

Is compounded semaglutide FDA approved?

No. Compounded drugs are not FDA-approved, and FDA states that it does not verify their safety, effectiveness or quality before they are marketed (FDA).

How do I check the pharmacy behind a clinic?

Ask for the name of the pharmacy, then look it up. A facility registered under section 503B appears in the FDA table of registered outsourcing facilities, and a state pharmacy appears in the license database of its state board of pharmacy (FDA).

Should I pay several months in advance?

Ask for cancellation and refund terms in writing first. Federal law requires a simple mechanism to stop recurring charges and disclosure of all material terms before billing (FTC).

Why does the price change when my dose changes?

Ask the clinic for the concentration on the label, how many days one vial should last, and the price at each dose step, then compare cost per day.

What is a 503B outsourcing facility?

A category of compounder created by section 503B of the federal Food, Drug, and Cosmetic Act. These facilities must follow current good manufacturing practice requirements and are inspected by FDA on a risk-based schedule (FDA).

Can I take a peptide labeled for research use only?

FDA states that it warned companies that sold unapproved drugs falsely labeled for research purposes or not for human consumption to consumers with dosing instructions, and that consumers should not purchase these products (FDA).

Sources:

This article is for general information. It is not medical advice, it does not recommend any drug, dose, pharmacy or provider, and it is not a substitute for a conversation with a clinician who knows your history. Talk to a clinician about your own situation.